Join us for Clear Horizons TV series 2 and 3, bringing you updates on SKYRIZI and special guest reports from leading psoriasis clinics.
Dr. Andrew Pink
Consultant dermatologist and clinical trials lead for adult medical dermatology at St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust.
Clear Horizons Broadcast 2020
Hear from international experts Dr Melinda Gooderham & Dr Ron Vender as they take you through Targeting IL-23 in Psoriasis and clinical data with a spotlight on SKYRIZI.
Clear Horizons: Alberto Barea
Join Nurse Consultant Alberto Barea as he presents on:
- The current context of biologics interventions – BAD Guidelines.
- The 4 pillars of biologics prescribing and where SKYRIZI fits within these criteria.
- Results from Risankizumab clinical trials.
- “Pop-up” Case studies.
- SKYRIZI: Summary of Product Characteristics.
UK-SKZD-210043. Date of preparation: February 2021.